Posted in | News | Water

Removing Mercury from Power Plant Flue Gas

Calgon Carbon Corporation announced today that it has been awarded a contract by a major U.S. power generator to supply Fluepac MC+ and Fluepac CF+ activated carbon to remove mercury from the flue gas of coal-fired power plants in the Midwest. Under terms of the guaranteed contract, the customer has agreed to purchase over the next five years a minimum amount of activated carbon valued at $55 million.

Fluepac MC+ and Fluepac CF+ are powdered activated carbons that were specifically developed by Calgon Carbon to remove mercury from power plant flue gas.

The five-year contract extends from 2008 through 2012, with major quantities scheduled for purchase in 2009 and beyond. Under terms of the contract, the customer may purchase more than the minimum requirements in years 2010 through 2012.

Commenting on the contract, Robert P. O'Brien, Calgon Carbon's senior vice president - Americas, said, "We are very pleased that a major U.S. power generator has selected Calgon Carbon to provide this critical product. We look forward to serving other customers in this important emerging market."

Calgon Carbon Corporation, headquartered in Pittsburgh, Pennsylvania, is a global leader in services and solutions for making water and air safer and cleaner.

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. This document contains certain statements that are forward-looking relative to the company's future strategy and performance. They involve known and unknown risks and uncertainties that may cause the company's actual results in future periods to be materially different from any future performance.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.